iBio, Inc.IBIONYSE
Loading
Year-over-year earnings per share growth rate
5Y CAGR
+20.6%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 17.55% |
| Q3 2025 | 64.52% |
| Q2 2025 | 36.73% |
| Q1 2025 | -2.08% |
| Q4 2024 | -4.35% |
| Q3 2024 | 48.89% |
| Q2 2024 | -5.88% |
| Q1 2024 | 80.77% |
| Q4 2023 | 7.72% |
| Q3 2023 | 19.36% |
| Q2 2023 | 46.29% |
| Q1 2023 | 83.84% |
| Q4 2022 | -66.86% |
| Q3 2022 | 95.80% |
| Q2 2022 | -3337.93% |
| Q1 2022 | -3.76% |
| Q4 2021 | -32.58% |
| Q3 2021 | -17316.67% |
| Q2 2021 | 100.67% |
| Q1 2021 | 17.72% |
| Q4 2020 | 6.88% |
| Q3 2020 | -81.88% |
| Q2 2020 | 56.64% |
| Q1 2020 | 91.37% |
| Q4 2019 | -232.89% |
| Q3 2019 | 9.77% |
| Q2 2019 | -2.66% |
| Q1 2019 | 8.09% |
| Q4 2018 | 2.74% |
| Q3 2018 | 26.63% |
| Q2 2018 | -13.33% |
| Q1 2018 | 25.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 20.00% |
| Q2 2017 | -25.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | -33.33% |
| Q3 2016 | 0.00% |
| Q2 2016 | -3105.13% |
| Q1 2016 | -28.93% |